Posts

Showing posts with the label Antidiabetics Market 2020

Antidiabetics Market Accounted At USD 84.13 Billion By 2020 : Grand View Research Inc.

San Francisco, 26 September 2019:   The Report   Antidiabetics Market   Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors, Meglitinides) And Segment Forecasts To 2020 Global antidiabetics market is expected to reach USD 84.13 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases. Future commercialization of products currently in the pipeline and the presence of large untapped opportunities in the emerging Asia Pacific and Latin American markets is expected to fuel future market growth. Insulin was the most revenue generating segment and its market was valued at over USD 20.0 billion in ...